Literature DB >> 12975295

Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma.

Massimiliano Filosto1, Michelangelo Mancuso, Yutaka Nishigaki, Jacklyn Pancrudo, Yadollah Harati, Clifton Gooch, Ami Mankodi, Lydia Bayne, Eduardo Bonilla, Sara Shanske, Michio Hirano, Salvatore DiMauro.   

Abstract

BACKGROUND: The mendelian forms of progressive external ophthalmoplegia (PEO) associated with multiple mitochondrial DNA deletions are clinically heterogeneous disorders transmitted as dominant or recessive traits. Autosomal dominant PEO is caused by mutations in at least 3 genes: adenine nucleotide translocator-1 (ANT1), encoding the muscle-specific adenine nucleotide translocator; chromosome 10 open reading frame 2 (C10orf2), encoding Twinkle helicase; and polymerase gamma (POLG), encoding the alpha subunit of polymerase gamma. Mutations in POLG can also cause autosomal recessive PEO, which is often associated with multisystemic disorders. OBJECTIVE AND METHODS: To further investigate the frequency and genotype-phenotype correlations of mutations in the POLG gene, we used single-stranded conformational polymorphism analysis and direct sequencing to screen 30 patients with familial or sporadic PEO and multiple mitochondrial DNA deletions in muscle but without mutations in ANT1 and C10orf2.
RESULTS: Four unrelated patients had novel POLG mutations. A woman with PEO and mental retardation had a heterozygous Gly1076Val mutation. Two patients, one with PEO, exercise intolerance, and gastrointestinal dysmotility and the other with PEO, neuropathy, deafness, and hypogonadism, both had a Pro587Leu change. The fourth patient, who was compound heterozygous for Ala889Thr and Arg579Trp mutations, had PEO, gastrointestinal dysmotility, and neuropathy. These mutations were not detected in 120 healthy control alleles.
CONCLUSIONS: Our results demonstrate that POLG mutations account for a substantial proportion of patients (13%) with PEO and multiple mitochondrial DNA deletions and cause both clinically and genetically heterogeneous disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12975295     DOI: 10.1001/archneur.60.9.1279

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  40 in total

1.  Humanin expression in skeletal muscles of patients with chronic progressive external ophthalmoplegia.

Authors:  Tesseki Kin; Kazuma Sugie; Makito Hirano; Yu-Ichi Goto; Ichizo Nishino; Satoshi Ueno
Journal:  J Hum Genet       Date:  2006-04-26       Impact factor: 3.172

Review 2.  Mitochondrial oxidative damage and apoptosis in age-related hearing loss.

Authors:  Shinichi Someya; Tomas A Prolla
Journal:  Mech Ageing Dev       Date:  2010-04-29       Impact factor: 5.432

3.  Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphismin mitochondrial disorders.

Authors:  Sherine S L Chan; Matthew J Longley; William C Copeland
Journal:  Hum Mol Genet       Date:  2006-11-06       Impact factor: 6.150

Review 4.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

5.  Synergistic Effects of the in cis T251I and P587L Mitochondrial DNA Polymerase γ Disease Mutations.

Authors:  Karen L DeBalsi; Matthew J Longley; Kirsten E Hoff; William C Copeland
Journal:  J Biol Chem       Date:  2017-02-02       Impact factor: 5.157

Review 6.  Hypogonadism and neurological diseases.

Authors:  Abdulaziz Alsemari
Journal:  Neurol Sci       Date:  2013-01-05       Impact factor: 3.307

Review 7.  Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.

Authors:  Ayman W El-Hattab; Fernando Scaglia
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

8.  Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk.

Authors:  C Lamperti; M Zeviani
Journal:  Acta Myol       Date:  2009-07

9.  Preliminary observations of mitochondrial dysfunction in Prader-Willi syndrome.

Authors:  Merlin G Butler; Waheeda A Hossain; Robert Tessman; Partha C Krishnamurthy
Journal:  Am J Med Genet A       Date:  2018-10-05       Impact factor: 2.802

10.  POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype.

Authors:  Tuomas Komulainen; Reetta Hinttala; Mikko Kärppä; Leila Pajunen; Saara Finnilä; Hannu Tuominen; Heikki Rantala; Ilmo Hassinen; Kari Majamaa; Johanna Uusimaa
Journal:  BMC Neurol       Date:  2010-05-03       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.